Uric Acid Concentration, Fructose Intake Up NASH in Children

Share this content:
Uric Acid Concentration, Fructose Intake Up NASH in Children
Uric Acid Concentration, Fructose Intake Up NASH in Children

WEDNESDAY, Feb. 15, 2017 (HealthDay News) -- Among children with non-alcoholic fatty liver disease (NAFLD), serum uric acid concentrations and fructose consumption are associated with non-alcoholic steatohepatitis (NASH), according to a study published online Feb. 14 in the Journal of Hepatology.

Antonella Mosca, M.D., from the Bambino Gesù Children's Hospital in Rome, and colleagues studied 271 obese children with NAFLD to examine factors associated with NASH. They assessed fructose consumption using a food frequency questionnaire and measured serum UA.

The researchers found that 37.6 percent of patients had NASH. Hyperuricemia (UA ≥ 5.9 mg/dL) was seen in 47 and 29.7 percent of patients with and without NASH, respectively (P = 0.003). After adjustment for multiple (and all) measured confounders, UA concentration and fructose consumption were independently associated with NASH (odds ratio, 2.488 [95 percent confidence interval, 1.87 to 2.83; P = 0.004] and 1.612 [95 percent confidence interval, 1.25 to 1.86; P = 0.001], respectively). There was an independent correlation for fructose consumption with hyperuricemia (odds ratio, 2.021 [95 percent confidence interval, 1.66 to 2.78; P = 0.01]).

"In conclusion, in a cohort of children and adolescents with a histological diagnosis of NAFLD and histological confirmation of NASH, we show for the first time that UA concentrations and dietary fructose consumption are independently and positively associated with NASH," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »